scholarly journals History of miscarriage as a risk factor for hepatitis C virus infection in pregnant Iraqi women

2002 ◽  
Vol 8 (2-3) ◽  
pp. 239-244
Author(s):  
W. A. Al Kubaisy ◽  
A. D. Niazi ◽  
K. Kubba
Keyword(s):  
Risk Factor ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Significant Risk ◽  
Significant Risk Factor ◽  
Hepatitis C Virus Infection ◽  
History Of ◽  
Iraqi Women ◽  
Hcv Genotyping

Sera from 3491 pregnant women were screened for the presence of HCV antibodies [anti-HCV]. HCV genotyping was also performed on the sera of 94 women. The overall anti-HCV seroprevalence was 3.21%. Anti-HCV seroprevalence was significantly positively correlated with the number of miscarriages. Miscarriage was a significant risk factor for the acquisition of HCV infection from the first miscarriage up to the fifth, the risk increasing with increasing number of miscarriages. A higher proportion of women with a history of miscarriage harboured HCV-1b compared to those with no miscarriage.

The Natural History of Hepatitis C Virus Infection in Hemophiliacs

Hematology ◽  
2001 ◽  
Vol 6 (2) ◽  
pp. 135-142 ◽  
Author(s):  
M. Franchini ◽  
A. Tagliaferri ◽  
G. Rossetti ◽  
F. Capra ◽  
E. De Maria ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Natural History ◽  
Virus Infection ◽  
Hepatitis C Virus Infection ◽  
History Of

Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort study

2021 ◽  
Author(s):  
Jean-Luc Szpakowski ◽  
Lue-Yen Tucker ◽  
David M Baer ◽  
Mary Pat Pauly
Keyword(s):  
Risk Factor ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Cancer Progression ◽  
Cancer Chemotherapy ◽  
Multivariable Analysis ◽  
Significant Risk ◽  
Significant Risk Factor ◽  
Hcv Infection ◽  
Grade 3

Background: The rates and causes of significant hepatotoxicity with cancer chemotherapy (CCT) in patients infected with hepatitis C virus (HCV) are incompletely characterized. Methods: We compared rates of grade 3 or 4 hepatotoxicity, defined as elevated transaminases, during CCT in patients who are mono-infected with HCV compared with rates in controls matched on demographics, diagnosis, and rituximab use. We excluded patients with hepatobiliary cancers, hepatitis B virus or human immunodeficiency virus infection. Hepatotoxicity was attributed to a medical cause, cancer progression, or CCT, including HCV flare. Results: Patients with HCV ( n = 196) had a higher rate of cirrhosis than the 1,130 matched controls (21.9% versus 4%; P <0.001). Their higher rate of overall hepatotoxicity (8.7% versus 4.5% of controls, P = 0.01 was due to higher rate of CCT-related hepatotoxicity (4.1% versus 1.2%, P = 0.01). On multivariable analysis, the largest risk factor for overall hepatotoxicity was cirrhosis, and the only risk factor for CCT-related hepatotoxicity was HCV infection. Among those with HCV, the only significant risk factor for hepatotoxicity was rituximab use. Hepatotoxicity caused by CCT delayed or altered treatment in only 3 HCV patients and 1 control (1.5% versus 0.1%, P = 0.01). Conclusions: Most patients with HCV can safely be treated with cancer chemotherapy. Cirrhosis and HCV infection contributed to increased hepatotoxicity in subjects on CCT. Among HCV patients, rituximab use was the major risk factor for increased hepatotoxicity. Hepatotoxicity due to CCT itself rarely altered or delayed CCT. Nonetheless, HCV-positive patients should be monitored carefully during CCT.

scholarly journals Hepatitis C Virus infection in apparentenly healthy individuals with family history of diabetes in Vom, Plateau State Nigeria

2009 ◽  
Vol 6 (1) ◽  
pp. 110 ◽  
Author(s):  
Obinna O Nwankiti ◽  
James A Ndako ◽  
Georgebest ON Echeonwu ◽  
Atanda O Olabode ◽  
Chika I Nwosuh ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Family History ◽  
Virus Infection ◽  
Hepatitis C Virus Infection ◽  
Healthy Individuals ◽  
Family History Of Diabetes ◽  
History Of ◽  
Plateau State

scholarly journals Hepatitis C virus infection in a male homosexual cohort: risk factor analysis.

1996 ◽  
Vol 72 (3) ◽  
pp. 213-216
Author(s):  
O K Ndimbie ◽  
L A Kingsley ◽  
S Nedjar ◽  
C R Rinaldo
Keyword(s):  
Factor Analysis ◽  
Risk Factor ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Risk Factor Analysis ◽  
Hepatitis C Virus Infection ◽  
Male Homosexual
Sign in / Sign up

Export Citation Format

Share Document